232 related articles for article (PubMed ID: 36466430)
1. Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals.
Mousavi Maleki MS; Sardari S; Ghandehari Alavijeh A; Madanchi H
Int J Pept Res Ther; 2023; 29(1):5. PubMed ID: 36466430
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Antiviral Peptides and Rational Biodesign Considerations.
Lee YJ; Shirkey JD; Park J; Bisht K; Cowan AJ
Biodes Res; 2022; 2022():9898241. PubMed ID: 37850133
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2.
Mousavi Maleki MS; Rostamian M; Madanchi H
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1205-1217. PubMed ID: 33844613
[No Abstract] [Full Text] [Related]
4. Antimicrobial Peptides as Potential Antiviral Factors in Insect Antiviral Immune Response.
Feng M; Fei S; Xia J; Labropoulou V; Swevers L; Sun J
Front Immunol; 2020; 11():2030. PubMed ID: 32983149
[TBL] [Abstract][Full Text] [Related]
5. Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2.
Tonk M; Růžek D; Vilcinskas A
Viruses; 2021 May; 13(5):. PubMed ID: 34069206
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
Sukmarini L
Molecules; 2022 Apr; 27(9):. PubMed ID: 35565968
[TBL] [Abstract][Full Text] [Related]
7. Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.
Zannella C; Chianese A; Palomba L; Marcocci ME; Bellavita R; Merlino F; Grieco P; Folliero V; De Filippis A; Mangoni M; Nencioni L; Franci G; Galdiero M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216177
[TBL] [Abstract][Full Text] [Related]
8. Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids.
Diamond G; Molchanova N; Herlan C; Fortkort JA; Lin JS; Figgins E; Bopp N; Ryan LK; Chung D; Adcock RS; Sherman M; Barron AE
Pharmaceuticals (Basel); 2021 Mar; 14(4):. PubMed ID: 33807248
[TBL] [Abstract][Full Text] [Related]
9. Antiviral peptides against Coronaviridae family: A review.
Heydari H; Golmohammadi R; Mirnejad R; Tebyanian H; Fasihi-Ramandi M; Moosazadeh Moghaddam M
Peptides; 2021 May; 139():170526. PubMed ID: 33676968
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
Saini J; Kaur P; Malik N; Lakhawat SS; Sharma PK
Microbiol Res; 2022 Dec; 265():127206. PubMed ID: 36162150
[TBL] [Abstract][Full Text] [Related]
11. Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.
Liu R; Liu Z; Peng H; Lv Y; Feng Y; Kang J; Lu N; Ma R; Hou S; Sun W; Ying Q; Wang F; Gao Q; Zhao P; Zhu C; Wang Y; Wu X
Front Immunol; 2022; 13():851642. PubMed ID: 35663971
[TBL] [Abstract][Full Text] [Related]
12. Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.
Sumon TA; Hussain MA; Hasan M; Rashid A; Abualreesh MH; Jang WJ; Sharifuzzaman SM; Brown CL; Lee EW; Hasan MT
Aquaculture; 2021 Aug; 541():736783. PubMed ID: 33883784
[TBL] [Abstract][Full Text] [Related]
13. Deepstacked-AVPs: predicting antiviral peptides using tri-segment evolutionary profile and word embedding based multi-perspective features with deep stacking model.
Akbar S; Raza A; Zou Q
BMC Bioinformatics; 2024 Mar; 25(1):102. PubMed ID: 38454333
[TBL] [Abstract][Full Text] [Related]
14. Animal venoms as a source of antiviral peptides active against arboviruses: a systematic review.
Lima WG; Maia CQ; de Carvalho TS; Leite GO; Brito JCM; Godói IPD; de Lima ME; Ferreira JMS
Arch Virol; 2022 Sep; 167(9):1763-1772. PubMed ID: 35723756
[TBL] [Abstract][Full Text] [Related]
15. Prediction of antiviral peptides derived from viral fusion proteins potentially active against herpes simplex and influenza A viruses.
Jesús T; Rogelio L; Abraham C; Uriel L; J-Daniel G; Alfonso MT; Lilia BB
Bioinformation; 2012; 8(18):870-4. PubMed ID: 23144542
[TBL] [Abstract][Full Text] [Related]
16. AVPIden: a new scheme for identification and functional prediction of antiviral peptides based on machine learning approaches.
Pang Y; Yao L; Jhong JH; Wang Z; Lee TY
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34279599
[TBL] [Abstract][Full Text] [Related]
17. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
18. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery.
Essa RZ; Wu YS; Batumalaie K; Sekar M; Poh CL
Pharmacol Rep; 2022 Dec; 74(6):1166-1181. PubMed ID: 36401119
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection.
Maiti BK
ACS Pharmacol Transl Sci; 2020 Aug; 3(4):783-785. PubMed ID: 32821885
[TBL] [Abstract][Full Text] [Related]
20. Antiviral peptides as promising therapeutic drugs.
Vilas Boas LCP; Campos ML; Berlanda RLA; de Carvalho Neves N; Franco OL
Cell Mol Life Sci; 2019 Sep; 76(18):3525-3542. PubMed ID: 31101936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
